Come up with a name for your new list and we'll add to it:
Tessera raised a round of funding on , . Investors include
Kirlan Venture Capital.
Tessera, Inc. is a biotechnology company that is dedicated to developing new, cutting-edge diagnostic products for the early detection of prostate and colon cancer using new, patented Nuclear Matrix P…